GSDMDC家族的基因功能

GSDMDC家族是近年来发现的一个全新的含有Gasdermin结构域的蛋白超家族,包括DFNA5、DFNA5L、GSDM、 GSDML 和 MLZE五个成员.研究表明GSDMDC家族可能与组织器官发育以及肿瘤,耳聋和脱发等遗传疾病相关,因而具有重要生理功能.其中,对该家族的DFNA5基因研究报道相对较多,它是常染色体显性非综合征性耳聋致病基因之一,并可能与黑色素瘤和乳腺癌相关.但对DFNA5基因在细胞和分子水平作用机制仍不清楚.对Gasdermin结构域的空间结构、特点、相互作用蛋白和生理功能也知之甚少.将来的研究将揭示此家族各成员的确切生理功能及其与疾病相关性.     

常染色体显性遗传非综合征型耳聋致病基因定位研究

耳聋具有高度的遗传异质性, 迄今已定位了51个常染色体显性遗传非综合征型耳聋(autosomal dominant non-syndromic sensorineural hearing loss, DFNA)基因位点, 20个DFNA相关基因被克隆.文章收集了一个DFNA巨大家系, 家系中有血缘关系的家族成员共170人, 对73名家族成员进行了详细的病史调查、全身检查和耳科学检查, 提示39人有不同程度的迟发性感音神经性听力下降, 未见前庭及其他系统的异常.应用ABI公司382个常染色体微卫星多态标记进行全基因组扫描连锁分析, 将该家系致聋基因定位于14q12-13处D14S1021-D14S70之间约7.6 cM (3.18 Mb)的区域, 最大LOD值为6.69 (D14S1040), 与已知DFNA9位点有4.7 cM (2.57 Mb)的重叠区, DFNA9致病基因COCH位于重叠区域内.下一步拟进行COCH基因的突变筛查, 以揭示该家系耳聋的分子致病机制.     

常染色体显性遗传非综合征性耳聋致病基因定位研究

耳聋具有高度的遗传异质性, 迄今已定位了51个常染色体显性遗传非综合征型耳聋(autosomal dominant non-syndromic sensorineural hearing loss, DFNA)基因位点, 20个DFNA相关基因被克隆。文章收集了一个DFNA巨大家系, 家系中有血缘关系的家族成员共170人, 对73名家族成员进行了详细的病史调查、全身检查和耳科学检查, 提示39人有不同程度的迟发性感音神经性听力下降, 未见前庭及其他系统的异常。应用ABI公司382个常染色体微卫星多态标记进行全基因组扫描连锁分析, 将该家系致聋基因定位于14q12-13处D14S1021-D14S70之间约7.6 cM (3.18 Mb)的区域, 最大LOD值为6.69 (D14S1040), 与已知DFNA9位点有4.7 cM (2.57 Mb)的重叠区, DFNA9致病基因COCH位于重叠区域内。下一步拟进行COCH基因的突变筛查, 以揭示该家系耳聋的分子致病机制。     

FHL1的结构和功能及其与疾病的关系

FHL（four and a half LIM domain）家族是含有4 个半LIM结构域的蛋白家族,现发现该家族由5 个成员,即FHL1、FHL2、FHL3、FHL4、FHL5 /ACT 组成,其表达具有组织特异性.它们通过LIM结构域与某些结构蛋白、激酶、转录调控因子等多种蛋白质相互作用,对某些基因的表达、细胞分化与发育、细胞骨架形成等发挥重要调控作用.FHL1（four and a half LIM domain 1）是FHL家族中表达最广泛的成员,尤其在骨骼肌和心肌中高表达.近年研究表明其参与某些病理过程,与心血管疾病、肌肉疾病、肿瘤疾病等相关.     

转录因子ZBTB家族与肿瘤

转录因子ZBTB家族是一类在N末端含有BTB结构域和在C末端含有多个锌指结构域的蛋白质。近年来,肿瘤基因组学的研究发现,编码该家族成员的多个基因在某些肿瘤中发生较高程度的突变、缺失或(和)扩增,这提示着ZBTB蛋白转录功能的紊乱可能与肿瘤的发生、发展相关。综述了ZBTB家族蛋白功能研究的最新进展,着重介绍了若干ZBTB蛋白与基因组稳定性的关系。     

跨膜丝氨酸蛋白酶研究进展

跨膜丝氨酸蛋白酶(TMPRSSs),又名II型跨膜丝氨酸蛋白酶(TTSPs)是一类定位于细胞膜上具有保守丝氨酸蛋白酶结构域的蛋白家族,哺乳动物中已发现二十多个成员.TMPRSSs 基本结构类似,C端蛋白酶结构域在胞外,N端位于胞内,还拥有单跨膜结构域,差异之处在于主干区.TMPRSSs具有多种重要生理功能,功能异常可造成耳聋、癌症、贫血和高血压等多种疾病.本文对TMPRSSs基本特征、结构、生理功能及相关疾病进行综述.     

砀山酥梨TCP基因家族全基因组鉴定与分析

TCP蛋白是植物特有的转录因子家族之一,在植物生长和发育等多个过程起到重要作用。本研究利用生物信息学方法对砀山酥梨TCP基因家族成员、染色体定位、进化分析、亚组分类、保守域结构和保守元件进行了相关分析。结果显示,梨TCP基因家族含有34个成员;进化分析表明,根据进化树拓扑结构将其分为两类:ClassⅠ和ClassⅡ,其中ClassⅡ可被分为CYC/TB1和CIN两个小组。结构域分析表明,梨TCP基因家族TCP结构域高度保守;保守元件分析表明,梨TCP基因家族包含5个保守元件:元件1是TCP保守域;元件2为R结构域,元件3、4和5为功能尚未鉴定的结构域,所有梨TCP蛋白都含有元件1,ClassⅡ组中CYC/TB1小组包含特异元件2。以上结果将为今后揭示梨TCP基因的功能提供重要的理论基础。     

FHL家族功能研究进展

FHL是含有4个半LIM结构域的蛋白家族,体内现已发现5个成员,即FHL1、FHL2、FHL3、FHL4、FHL5/ACT,不同成员在组织中表达具有特异性。FHL家族通过LIM结构域与其他蛋白质相互作用,在各种肌细胞的生长与分化、肿瘤的发生发展以及基因的转录调节中发挥重要的作用。     

真菌中锌簇蛋白的结构和功能

锌簇家族蛋白即Zn₂Cys₆类锌指蛋白,是真菌中特有的一类蛋白,它们属于转录因子类,广泛参与真菌中初级和次级代谢、胁迫应答和细胞分裂等生命活动的调控。锌簇蛋白主要包括N端的DNA结合结构域、中间的调节结构域和C端的酸性区域,其中DNA结合结构域包含锌指基序并负责结合靶基因的启动子。目前已经解析了多个锌簇家族转录因子DNA结合结构域的三维结构,并发现该家族中一些蛋白能够参与调控多个基因的表达,但缺乏对其结构、动力学和功能关系的全面分析。本文综合分析了不同锌簇蛋白与DNA结合的结构特征,总结其结构域与功能的关系,指出锌簇蛋白研究的重要方向,旨在为锌簇家族蛋白的深入研究提供思路。     

大豆UBC基因家族鉴定及GmUBC46基因的功能初步分析

泛素/26S蛋白酶体途径在植物响应非生物胁迫反应中起着重要的作用。E2(泛素结合酶,UBC)是蛋白质泛素化中重要的泛素结合酶,与E1和E3共同参与蛋白降解途径。本研究通过构建隐马尔可夫模型,鉴定了54个大豆UBC基因,通过进化树分析将该家族成员分为11个亚家族(A-K)。蛋白保守结构域分析表明,GmUBC家族蛋白成员大部分含有保守Motif 1、Motif 2与Motif 3,且均属于泛素结合酶保守结构域。组织定位分析表明大部分GmUBC家族基因成员在大豆根、茎、叶、花等组织中有所表达。转录组数据表明有20个GmUBC基因在干旱、盐或冷胁迫下具有不同的表达模式,启动子顺式作用元件分析发现其胁迫响应过程可能与激素信号转导相关。进一步通过qRT-PCR发现GmUBC46基因能积极响应干旱、盐或冷胁迫诱导上调表达。通过酵母功能验证表明,GmUBC46基因降低了对干旱或盐胁迫的耐受性。综上,本研究初步阐明了大豆UBC基因家族的基本特性及GmUBC46基因的耐逆功能,为后续研究提供了重要依据和参考价值。     

Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner

Gasdermin (Gsdm) was originally identified as a candidate causative gene for several mouse skin mutants. Several Gsdm-related genes sharing a protein domain with DFNA5, the causative gene of human nonsyndromic hearing loss, have been found in the mouse and human genomes, and this group is referred to as the DFNA5-Gasdermin domain family. However, our current comparative genomic analysis identified several novel motifs distinct from the previously reported domain in the Gsdm-related genes. We also identified three new Gsdm genes clustered on mouse chromosome 15. We named these genes collectively the Gsdm family. Extensive expression analysis revealed exclusive expression of Gsdm family genes in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner. Further database searching revealed the presence of other related genes with a similar N-terminal motif. These results suggest that the Gsdm family and related genes have evolved divergent epithelial expression profiles.     

Mechanisms of Gasdermin Family Members in Inflammasome Signaling and Cell Death

The Gasdermin (GSDM) family consists of Gasdermin A (GSDMA), Gasdermin B (GSDMB), Gasdermin C (GSDMC), Gasdermin D (GSDMD), Gasdermin E (GSDME) and Pejvakin (PJVK). GSDMD is activated by inflammasome-associated inflammatory caspases. Cleavage of GSDMD by human or mouse caspase-1, human caspase-4, human caspase-5, and mouse caspase-11 liberates the N-terminal effector domain from the C-terminal inhibitory domain. The N-terminal domain oligomerizes in the cell membrane and forms a pore of 10–16?nm in diameter, through which substrates of a smaller diameter, such as interleukin-1β and interleukin-18, are secreted. The increasing abundance of membrane pores ultimately leads to membrane rupture and pyroptosis, releasing the entire cellular content. Other than GSDMD, the N-terminal domain of all GSDMs, with the exception of PJVK, have the ability to form pores. There is evidence to suggest that GSDMB and GSDME are cleaved by apoptotic caspases. Here, we review the mechanistic functions of GSDM proteins with respect to their expression and signaling profile in the cell, with more focused discussions on inflammasome activation and cell death.     

Li-Fraumeni Syndrome: a p53 Family Affair

The p53 alterations frequently found in human tumors are missense mutations in the DNA binding domain. These p53 mutations have been shown to have gain-of-function or dominant negative properties in multiple experiments. The consequences of these p53 mutations at physiological levels on the development of a tumor were unclear. Using mouse models, three recent papers have shed light on the mechanisms of mutant p53 and its family members, p63 and p73, in tumorigenesis. Interestingly, the p53 point mutant mice had a similar phenotype to p53 family compound mutant mice suggesting that there is an interplay between the p53 family members in tumorigenesis and Li-Fraumeni syndrome.     

Physiology and pathophysiology of matrix metalloproteases

Matrix metalloproteases (MMPs) comprise a family of enzymes that cleave protein substrates based on a conserved mechanism involving activation of an active site-bound water molecule by a Zn²⁺ ion. Although the catalytic domain of MMPs is structurally highly similar, there are many differences with respect to substrate specificity, cellular and tissue localization, membrane binding and regulation that make this a very versatile family of enzymes with a multitude of physiological functions, many of which are still not fully understood. Essentially, all members of the MMP family have been linked to disease development, notably to cancer metastasis, chronic inflammation and the ensuing tissue damage as well as to neurological disorders. This has stimulated a flurry of studies into MMP inhibitors as therapeutic agents, as well as into measuring MMP levels as diagnostic or prognostic markers. As with most protein families, deciphering the function(s) of MMPs is difficult, as they can modify many proteins. Which of these reactions are physiologically or pathophysiologically relevant is often not clear, although studies on knockout animals, human genetic and epigenetic, as well as biochemical studies using natural or synthetic inhibitors have provided insight to a great extent. In this review, we will give an overview of 23 members of the human MMP family and describe functions, linkages to disease and structural and mechanistic features. MMPs can be grouped into soluble (including matrilysins) and membrane-anchored species. We adhere to the ‘MMP nomenclature’ and provide the reader with reference to the many, often diverse, names for this enzyme family in the introduction.     

Identification of a novel mutation in WFS1 in a family affected by low-frequency hearing impairment

Previously we confirmed linkage of autosomal dominantly inherited low-frequency sensorineural hearing impairment (LFSNHI) in a German family to the genetic locus DFNA6/DFNA14 on chromosome 4p16.3 close to the markers D4S432 and D4S431. Analysis of data from the Human Genome Project, showed that WFS1 is located in this region. Mutations in WFS1 are known to be responsible for Wolfram syndrome (DIDMOAD, MIM #606201), which follows an autosomal recessive trait. Studies in low-frequency hearing loss families showed that mutations in WFS1 were responsible for the phenotype. In all affected family members analysed, we detected a missense mutation in WFS1 (K705N) and therefore confirm the finding that the majority of mutations responsible for LFSNHI are missense mutations which localise to the C-terminal domain of the protein.     

Identification and Functional Study of a New Missense Mutation in the Motor Head Domain of Myosin VIIA in a Family with Autosomal Dominant Hearing Impairment (DFNA11)

The MYO7A encodes a protein classified as an unconventional myosin. Here, we present a family with non-syndromic autosomal dominant hearing impairment that clinically resembles other previously published DFNA11 families. Affected members of the family present with an ascending audiogram affecting low and middle frequencies at young ages and then affecting all frequencies with increasing age. Genome-wide linkage analysis using Illumina Cyto-12 Chip mapped the disease locus to the DFNA11 interval in the family. A c.2003G→A (p.R668H) mutation of the MYO7A, is heterozygous in all affected family members and absent in 100 healthy individuals. Arg668His is located in a region of the myosin VIIA motor domain that is highly conserved among different species. Molecular modeling predicts that the conserved R668 residue plays important structural role in linking different lobes of motor domain together. In the actin-activated ATPase activity assay, the rate of NADH oxidation was higher in the wild-type myosin VIIA, indicating that the ATPase activity in the p.R668H mutant myosin VIIA was significantly destroyed.     

Alpha-tectorin involvement in hearing disabilities: one gene – two phenotypes

The human alpha-tectorin (TECTA) gene has recently been cloned and proposed to be involved in autosomal dominant non-syndromic hearing impairment (NSHI) in two families linked to the DFNA12 locus. We have studied a Swedish pedigree with autosomal dominant NSHI with possible digenic inheritance of the disease, involving locus DFNA12 in chromosome 11 and locus DFNA2 in chromosome 1. Mutation analysis of the TECTA gene in this family has identified eight nucleotide substitutions indicating that TECTA is highly polymorphic. One of the changes results in a cysteine to serine (C 1057 S) mutation, in the zonadhesin domain of TECTA; this segregates with the disease haplotype on chromosome 11 and is not present in a control population. The mutation results in the replacement of a cysteine in one of the repeats of the zonadhesin/Von Willebrand domain of the protein and might cause a change in the crosslinking of the polypeptide. These findings add support to the involvement of TECTA in hearing disabilities. However, the three families carrying different TECTA mutations also show phenotypic differences: the hearing loss ranges from prelingual to progressive with late onset. The explanation for the different phenotypes and some clues regarding the functions of TECTA may lie in the localization of the mutations in the different modules of the protein. Another possibility is that the phenotype in the Swedish family is the result of two defective genes.     

A yeast model for the study of human DFNA5, a gene mutated in nonsyndromic hearing impairment

A mutation in human DFNA5 is associated with autosomal dominant nonsyndromic hearing impairment. The function of DFNA5 protein remains unknown and no experimental model has been described so far. Here we describe fission yeast Schizosaccharomyces pombe as a model organism for studying the function of heterologously expressed DFNA5. We have expressed wild-type as well as mutant DFNA5 alleles under control of regulatable nmt1 promoter. Yeast cells tolerated expression of wild-type DFNA5, while expression of the mutant DFNA5 allele, which is responsible for nonsyndromic autosomal dominant hearing impairment, led to cell cycle arrest. We identified new rat and horse DFNA5 homologues and we describe a domain of homology shared between DFNA5 and the Mcm10 family of DNA replication proteins. Genetic interactions between heterologously expressed DFNA5 and a fission yeast cdc23 (mcm10) mutant support a possible link between DFNA5 and Mcm10 proteins.     

Regulatory roles and molecular signaling of TNF family members in osteoclasts

The tumor necrosis factor (TNF) family has been one of the most intensively studied families of proteins in the past two decades. The TNF family constitutes 19 members that mediate diverse biological functions in a variety of cellular systems. The TNF family members regulate cellular functions through binding to membrane-bound receptors belonging to the TNF receptor (TNFR) family. Members of the TNFR family lack intrinsic kinase activity and thus they initiate signaling by interacting intracellular signaling molecules such as TNFR associated factor (TRAF), TNFR associated death domain (TRADD) and Fas-associated death domain (FADD). In bone metabolism, it has been shown that numerous TNF family members including receptor activator of nuclear factor kappaB ligand (RANKL), TNF-alpha, Fas ligand (FasL) and TNF-related apoptosis-inducing ligand (TRAIL) play pivotal roles in the differentiation, function, survival and/or apoptosis of osteoclasts, the principal bone-resorbing cells. These TNF family members not only regulate physiological bone remodeling but they are also implicated in the pathogenesis of various bone diseases such as osteoporosis and bone loss in inflammatory conditions. This review will focus on our current understanding of the regulatory roles and molecular signaling of these TNF family members in osteoclasts.